1-7 of 7
M Hussein
Close
Sort by
Journal Articles

Efficacy and Cost Effectiveness of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in Adult Patients with Iron Deficiency Anemia

Ahmed Basha, BSC, Mohamed Izham, PhD, Anas Hamad, PhD, Prem Chandra, PhD, Nabil E Omar, PharmD, Mohammad Abdul-Jaber Abdulla, MD, Mahmood B Aldapt, MD, Radwa M Hussein, BSC, Ahmed Mahfouz, MSc, Ahmed A Adel, BSC, Hawraa M Shwaylia, MD, Yeslem Mohamed Aly Ekeibed, MBBS, MD, Rami AbuMousa, MSc (pharm), Mohamed A Yassin, MBBS, MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-134537
Published: 2020
Journal Articles

The Impact of Ethnicity on the Response to Eltrombopag in Patients with Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience

Mohamed A Yassin, MBBS, MSc, Aya Alasmar, BSC, Rola Ghasoub, BSC, Omer Ismail, MD CABM, Abdulqadir Jeprel Nashwan, BSN, MSN, Firdous Ghori, MBBS CABM, Deena Sideeg, MBBS MRCP, Radwa M Hussein, BSC, Randa Al -Okka, BSC, Prem Chandra, PhD, Anas Hamad, PhD, Ashraf Tawfiq Soliman, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-134416
Published: 2020
Journal Articles

Jadenu Substituting Exjade in Beta Thalassemia Major (BTM) Patients with Iron Overload: Effect on Serum Ferritin Concentration, Liver Iron Content and Biochemical Profiles

Mohamed A Yassin, MBBS, MSc, Abdulqadir Nashwan, MSc, Nancy Kassem, BSC, Ashraf Tawfiq Soliman, MD PhD, Vincenzo De Sanctis, Ahmed A Adel, BSC, Radwa M Hussein, BSC, Ahmed Basha, BSC, Randa Al -Okka, BSC, Rula Ghasoub, BSC
Journal: Blood
Blood (2018) 132 (Supplement 1): 4905.
https://doi.org/10.1182/blood-2018-99-113998
Published: 2018
Journal Articles

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

Andrzej J Jakubowiak, MD, PhD, Dominik Dytfeld, MD, PhD, Sundar Jagannath, MD, David H. Vesole, MD, PhD, Tara B. Anderson, Brian K. Nordgren, Kristen Detweiler-Short, Daniel Lebovic, MD, Keith E. Stockerl-Goldstein, MD, Kent A. Griffith, Terri L. Jobkar, BSN, Diane E Durecki, BA, Sandra M. Wear, RN, Robert F Ott, MBA, Ammar Al-Zoubi, MD, Melissa A Mietzel, M.S. CCRP, M Hussein, Daniel Couriel, MD, Joseph A Leveque, MD, Ravi Vij, MD
Journal: Blood
Blood (2011) 118 (21): 631.
https://doi.org/10.1182/blood.V118.21.631.631
Published: 2011
Journal Articles

Full Dose Vincristine (V) Negatively Impacts Progression Free Survival in Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients Treated with Pegylated Doxorubicin, Vincristine, Reduced-Dose Dexamethasone, and Thalidomide (DVd-T).

R. Suppiah, MD, E. Walker, PhD, K. Almhanna, MD, MPH, S. Andresen, DO, J. Reed, RN, M. Karam, RN, B. Phillips, M. Kelly, E. Ellis, B. McGowan, M. Hussein, MD
Journal: Blood
Blood (2005) 106 (11): 2570.
https://doi.org/10.1182/blood.V106.11.2570.2570
Published: 2005
Journal Articles

A randomized placebo-controlled trial of recombinant human interleukin- 11 in cancer patients with severe thrombocytopenia due to chemotherapy

I Tepler, L Elias, JW 2nd Smith, M Hussein, G Rosen, AY Chang, JO Moore, MS Gordon, B Kuca, KJ Beach, JW Loewy, MB Garnick, JA Kaye
Journal: Blood
Blood (1996) 87 (9): 3607–3614.
https://doi.org/10.1182/blood.V87.9.3607.bloodjournal8793607
Published: 1996
Journal Articles

Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes

V Ratanatharathorn, C Karanes, J Uberti, LG Lum, MM de Planque, KR Schultz, S Cronin, ME Dan, A Mohamed, M Hussein
Journal: Blood
Blood (1993) 81 (8): 2194–2199.
https://doi.org/10.1182/blood.V81.8.2194.2194
Published: 1993